Chart Review of Repatha® in Subjects With Hyperlipidaemia

Carotid Atorvastatin Study in Hyperlipidemic Post-Menopausal Women

NCT00163163 ·Status: COMPLETED ·Phase: PHASE3

Evaluate the Effect of Obicetrapib in Patients With HeFH on Top of Maximum Tolerated Lipid-Modifying Therapies.

NCT05425745 ·Status: COMPLETED ·Phase: PHASE3

Effects of Evolocumab Versus Placebo Added to Standard Lipid-lowering Therapy on Fasting and Post Fat Load Lipids in Patients With Familial Dysbetalipoproteinemia

NCT03811223 ·Status: UNKNOWN ·Phase: PHASE4

Study to Compare the Efficacy and Safety of Pitavastatin and Simvastatin

NCT00309738 ·Status: COMPLETED ·Phase: PHASE3

Study to Assess the Efficacy and Safety of LIB003 in HeFH Patients on Oral Lipid Therapy Needing Further LDL-C Reduction

NCT04797104 ·Status: COMPLETED ·Phase: PHASE3

Pleiotropic Effects of Atorvastatin in High Cardiovascular Risk Patients

NCT01013103 ·Status: COMPLETED ·Phase: PHASE4

A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

NCT06686615 ·Status: RECRUITING

Open-label Extension Study of Evolocumab (AMG 145) in Adults With Hyperlipidemia and Mixed Dyslipidemia

NCT01854918 ·Status: COMPLETED ·Phase: PHASE3

Long-Term Extension Study of Pitavastatin in Patients With Primary Hypercholesterolemia or Combined Dyslipidemia

NCT00325780 ·Status: COMPLETED ·Phase: PHASE3

Impact of Obicetrapib and Obicetrapib Plus Repatha on Lp(a) Levels

NCT06496243 ·Status: RECRUITING ·Phase: PHASE2

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

NCT03135184 ·Status: UNKNOWN ·Phase: NA

Lipid Management in Clinical Practice (MK-0524A-115)

NCT01071278 ·Status: COMPLETED

Use of Atorvastatin (Lipitor) to Decrease Panel Reactive Antibody Titers

NCT00143741 ·Status: COMPLETED ·Phase: PHASE1

A Study Comparing the Mechanisms of Action of Lifibrol and Pravastatin

NCT01057654 ·Status: COMPLETED ·Phase: PHASE3

A Comparison of Atorvastatin and Glimepiride Fixed Dose Combination and Atorvastatin and Glimepiride Loose Combination in the Treatment of Patients With Type 2 Diabetes Mellitus

NCT01495013 ·Status: COMPLETED ·Phase: PHASE3

A Multiple Ascending Dose Study of HTD1801 in Adults With Hypercholesterolemia

NCT03381287 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

The Effect of Anacetrapib on Vascular Function and Arterial Stiffness

NCT02931188 ·Status: COMPLETED

Evaluation of Adherence, Persistence and Efficacy of Treatment With PCSK9 Inhibitors in Italy

NCT05430828 ·Status: RECRUITING

Centralized Pan-Middle East Survey on the Under-treatment of Hypercholesterolemia, Sub-study for the Gulf States

NCT01031277 ·Status: COMPLETED

Long-term Efficacy and Safety of OLE LIB003 in HoFH, HeFH, and High-risk CVD Patients Requiring Further LDL-C Reduction

NCT04798430 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3

A Study in People With High Cholesterol

NCT00133380 ·Status: COMPLETED ·Phase: PHASE2

Atlantic Lipid Lowering Treatment Optimization Program

NCT06439654 ·Status: RECRUITING ·Phase: NA

Study of Undertreatment of Patients With Dyslipidemia in Bulgaria

NCT01075594 ·Status: COMPLETED

Efficacy of Lapaquistat Acetate and Simvastatin in Subjects With Primary Dyslipidemia.

NCT00256178 ·Status: COMPLETED ·Phase: PHASE3

Lipid-lowering Effects of Gefarnate in Statin-treated Coronary Heart Disease Patients With Residual Hypertriglyceridemia

NCT03610321 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3